The Comparison of Dengue Haemorrhagic Fever Cases in Indonesia During the COVID-19 Pandemic

Since the emergence of the COVID-19 pandemic at the end of 2019, several problems in the world of health have been focused on handling the COVID-19 disease. Hence, it does not spread further out in the world and does not cause severe consequences. As is known, sufferers of the disease are due to the SAR COV-2 virus which infects many patients due to COVID-19. This study aims to depict the incidence rate (IR), Case Fatality Rate (CFR) of Dengue Haemorrhagic Fever (DHF) in Indonesia, and its comparison of the number of cases during the COVID-19 pandemic.  As many as 452535 DHF cases from 2021 to 2022 were further analysed in this study. The data were analysed using univariate and bivariate analysis. The T-test was used to compare the number of cases in 2021 and 2022. The number of cities in Indonesia reported the DHF reached the highest during the COVID-19 pandemic and spread in 481 urban districts in 2019. The IR in Indonesia in 2021 was considerably higher than in 2022 in the same month. However, this was slightly in contrast to the CFR value in 2022 which has a higher value in 2022 compared with 2021 in the same month. There was a significant comparison between the number of DHF cases in 2021 and 2022 with a p-value < 0.05. Several measures can be taken to mitigate the increase in the incidence rate of DHF during the COVID-19 pandemic and thereafter.